Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 04-2018 | 01-2018 | 10-2017 | 07-2017 | 04-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 270 | 190 | 520 | 950 | 900 |
| Marketable Securities | 3,130 | 280 | 520 | 570 | 710 |
| Receivables | 20 | 0 | 0 | 10 | 0 |
| Other current assets | 20 | 10 | 10 | 10 | 20 |
| TOTAL | $3,440 | $480 | $1,050 | $1,540 | $1,630 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 290 | 300 | 300 | 0 | 0 |
| TOTAL | $290 | $300 | $300 | $N/A | $N/A |
| Total Assets | $3,730 | $780 | $1,350 | $1,540 | $1,630 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 990 | 0 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 380 | 320 | 340 | 360 | 10 |
| Other current liabilities | 0 | 0 | 0 | 480 | 0 |
| TOTAL | $1,370 | $320 | $340 | $830 | $10 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,370 | $320 | $340 | $830 | $10 |
| Shareholders' Equity | |||||
| Common Shares | 8,110 | 6,380 | 6,090 | 4,980 | 4,890 |
| Retained earnings | -9,090 | -7,860 | -7,180 | -6,280 | -5,640 |
| Other shareholders' equity | 3,340 | 1,940 | 2,100 | 2,000 | 2,370 |
| TOTAL | $2,360 | $460 | $1,010 | $700 | $1,620 |
| Total Liabilities And Equity | $3,730 | $780 | $1,350 | $1,530 | $1,630 |